|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ch. 17
|
|
2000 LAWS OF MARYLAND
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(B) THE PURPOSE OF THE ADMINISTRATIVE COMPONENT IS TO PROVIDE THE
NECESSARY ADMINISTRATIVE STRUCTURE FOR EFFECTIVE MANAGEMENT OF THE
PROGRAM.
(C) THE ANNUAL BUDGET BILL SHALL SPECIFY THE AMOUNT OF FUNDING
THAT IS ALLOCATED TO THE DEPARTMENT UNDER THE ADMINISTRATIVE
COMPONENT TO COVER ADMINISTRATIVE COSTS OF THE PROGRAM, INCLUDING
COSTS INCURRED BY THE DEPARTMENT, A COUNTY, OR ANY PERSON RECEIVING
MONEY UNDER A LOCAL PUBLIC HEALTH TOBACCO GRANT.
(D) THE AMOUNT THAT IS ALLOCATED TO THE ADMINISTRATIVE COMPONENT
UNDER SUBSECTION (C) OF THIS SECTION WHICH MAY NOT EXCEED 5 PERCENT OF
THE AMOUNT THAT IS ALLOCATED TO THE PROGRAM IN THE STATE BUDGET.
(D) THE ADMINISTRATIVE COSTS INCURRED BY ANY ENTITY THAT RECEIVES
FUNDS UNDER ANY OTHER COMPONENT OF THE PROGRAM, WHICH MAY NOT
EXCEED 7 PERCENT OF THE FUNDS GRANTED ANNUALLY TO EACH ENTITY, ARE NOT
INCLUDED IN THE ADMINISTRATIVE COMPONENT.
13-1015.
THE DEPARTMENT SHALL ADOPT ANY REGULATIONS NECESSARY TO CARRY
OUT THE PROVISIONS OF THIS SUBTITLE.
SUBTITLE 11. CANCER AND TOBACCO RELATED DISEASES PREVENTION,
IDENTIFICATION, AND TREATMENT PROGRAM.
13-1101.
(A) IN THIS SUBTITLE THE FOLLOWING WORDS HAVE THE MEANINGS
INDICATED.
(B) "ADMINISTRATIVE COMPONENT" MEANS THE COMPONENT OF THE
PROGRAM ESTABLISHED UNDER § 13-1110 13-1120 OF THIS SUBTITLE.
(C) "BASELINE CANCER STUDY" MEANS THE STUDY CONDUCTED UNDER §
13-1103 OF THIS SUBTITLE.
(D) "CANCER PREVENTION, IDENTIFICATION, AND TREATMENT MAJOR
COMMUNITY HOSPITAL COMPONENT" MEANS THE COMPONENT OF THE PROGRAM
ESTABLISHED UNDER § 13-1107 13-1106 OF THIS SUBTITLE.
(E) "CANCER AND TOBACCO RELATED DISEASES PRIMARY HEALTH CARE
PROGRAM" MEANS THE PROGRAM ESTABLISHED IN § 13-1109 OF THIS SUBTITLE.
(F) (E) "CIGARETTE RESTITUTION FUND" MEANS THE FUND THAT IS
ESTABLISHED UNDER § 7-317 OF THE STATE FINANCE AND PROCUREMENT ARTICLE.
(G) (F) "CLINICAL RESEARCH" MEANS RESEARCH THAT INVOLVES FORMAL
TESTING OF HUMANS FOR THE SAFETY AND EFFECTIVENESS OF PROMISING NEW
TREATMENT PROTOCOLS TREATMENTS AND PROTOCOLS INVOLVING HUMAN
SUBJECTS AND OTHER APPLICABLE MODELS FOR TESTING.
|
|
|
|
|
|
|
|
|
|
- 206 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
